Frequency of cardiovascular risk factors in patients with hypertension in a second level hospital

Authors

  • José W. Martinez Technological University of Pereira
  • Julián A. Villa P. Technological University of Pereira
  • Ana M. Quintero B. Technological University of Pereira
  • Johana Jaramillo A. Technological University of Pereira
  • Viviana Calderón F. Technological University of Pereira
  • Ángela V. Copete M. Technological University of Pereira

DOI:

https://doi.org/10.17533/udea.rfnsp.5246

Keywords:

risk factors, hypertension, patient adherence

Abstract

Objective: to determine the frequency of exposure to four cardiovascular risk factors in patients from a hypertension control program. This program belongs to a second level hospital located in Risaralda, Colombia. Methodology: a total of 133 patients from a hypertension control program were assessed. The Martin-Bayarre-Grau test (MBG test), the body mass index, and the blood pressure measurements were used as instruments for measuring adherence to treatment. Results: 80% of the patients were female. The average systolic and diastolic arterial pressure values were 141 and 86 mm Hg respectively. 74% of the patients exhibited overweight and obesity, and only 42.1% of the patients showed complete adherence to the antihypertensive therapy. Additionally, 100% of the patients had at least one of the assessed cardiovascular risks. Conclusions: high frequency of exposure to cardiovascular risks is an indicator of the lack of treatment adherence. An interdisciplinary team is needed to ensure that patients understand their disease and to develop strategies to improve adherence.

|Abstract
= 393 veces | PDF (ESPAÑOL (ESPAÑA))
= 84 veces|

Downloads

Download data is not yet available.

Author Biographies

José W. Martinez, Technological University of Pereira

Doctor in epidemiology; professor of the medicine and surgery program, Department of Community Medicine, Technological University of Pereira, Pereira, Colombia.

Julián A. Villa P., Technological University of Pereira

Medical student; Technological University of Pereira, Pereira, Colombia.

Ana M. Quintero B., Technological University of Pereira

Medical student; Technological University of Pereira, Pereira, Colombia.

Johana Jaramillo A., Technological University of Pereira

Medical student; Technological University of Pereira, Pereira, Colombia.

Viviana Calderón F., Technological University of Pereira

Medical student; Technological University of Pereira, Pereira, Colombia.

Ángela V. Copete M., Technological University of Pereira

Student of the medicine and surgery program; Technological University of Pereira, Pereira, Colombia.

References

(1). World Health Organization, editor. Informe sobre la salud en el mundo 2002. Reducir riesgos y promover una vida sana. Gi-nebra: who; 2002.

(2). Fluixá C, Franc M. Qué significa riesgo cardiovascular. Como podemos reducirlo[internet]. Valencia: Societat Valenciana de Medicina Familiar i Comunitària.2011. [acceso 20 de febrero de 2011]. Disponible en:www.svmfyc.org/Grupos/Hojaspacientes/20.pdf.

(3). Giraldo J, Granada P, Zapata C, Rueda J, Cediel V, Martínez J, et al. Riesgo cardiovascular en docentes y administrativos de la Universidad Tecnológica de Pereira. Pereira: Publiprint Ltda; 2010. págs. 9-99.

(4). National Institutes of Health, National Heart, Lung, and Blood Institute. The Executive Committee of the National Heart L, and Blood Institute. The Seventh Report of the Joint National Com-mittee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Washington: nih; 2004.

(5). Berrington A, Hartge P, Cerhan J, Flint A, Hannan L, MacInnis R. et al. Body-Mass Index and Mortality among 1.46 Million White Adults. N Engl J Med 2010; 363: 2211-2219. DOI: https://doi.org/10.1056/NEJMoa1000367

(6). Palop V, Martínez I. Adherencia al tratamiento en el paciente an-ciano. Inf Ter Sist Nac Salud 2004; 28(5): 113-120.

(7). Estrada M. Pauta posológica y su cumplimiento. Offarm 2006; 10(25): 96-102.

(8). Rodríguez J, Ruiz F, Peñalosa E, Eslava J, Gómez L, Sánchez J,et al. Encuesta Nacional de Salud 2007. Departamento Risaralda. Bogotá: javegraf; 2009.págs. 20-27.

(9). Oficina de comunicaciones y atención al ciudadano. Encuesta nacional de La situación nutricional en Colombia, 2005 [internet]. Bogotá: Instituto Colombiano de Bienestar Familiar; 2006 [acceso 5 de marzo de 2011]. Disponible en: http://www.icbf.gov.co/icbf/directorio/portel/libreria/pdf/1ENSINLIBROCOMPLETO.pdf.

(10). National Heart, Lung, and Blood Institute. Guidelines on Over-weight and Obesity: Electronic Textbook [libro en internet]. Bethes-da: nhlbi. [acceso 23 de julio de 2008]. Disponible en: http://www.nhlbi.nih.gov/guidelines/obesity/e_txtbk/txgd/4142.htm.

(11). Libertad M, Bayarré H, Grau J. Validación del cuestionario mbg(Martín-Bayarre-Grau) para evaluar la adherencia terapéutica en hipertensión arterial. Rev. Cubana Salud Pública. [revista en internet]. 2008 enero-marzo. [acceso 7 de abril de 2009]; 34(1): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S086434662008000100012&lng=es. DOI: https://doi.org/10.1590/S0864-34662008000100012

(12). Sabaté E, Organización Mundial de la Salud. Adherencia a los tratamientos a largo plazo: pruebas para la acción. Washington: oms; 2004.

(13). Hughes D, Bagust A, Haycox A, Walley T. The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a re-view of the literature Health Econ 2001; 10: 601-615. DOI: https://doi.org/10.1002/hec.609

(14). Pladevall M, Divine G, Williams L, Xi H, Potts L, Lafata J. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004; 27(12): 2800-2805. DOI: https://doi.org/10.2337/diacare.27.12.2800

(15). Hansen R, Seifeldin R, Noe L. Medication adherence in chronic disease: issues in post transplant immunosuppression. Transplant Proc 2007; 39(5): 1287-1300. DOI: https://doi.org/10.1016/j.transproceed.2007.02.074

(16). Simpson S, Eurich D, Majumdar S, Padwal R, Tsuyuki R, Varney J, et al. A metaanalysis of the association between adherence to drug therapy and mortality. bmj 2006; 333: 15-20. DOI: https://doi.org/10.1136/bmj.38875.675486.55

(17). Herrera R, Badiel M, Zapata H.Factores asociados al no control de la presión arterial en pacientes inscritos al programa de hi-pertensión de una Entidad Promotora de Salud en Cali-Colombia, 2004.Rev Colomb Cardiol 2009; 16(4): 143-152.

(18). Navarrete S, Huertas D, Rozo L, Ospina J. Prevalencia de factores de riesgo para enfermedad cardiovascular en una muestra de pacientes con hipertensión arterial esencial: estudio descrip-tivo. Rev. Colomb. Cardiol 2009, 16, (2): 64-70.

(19). Holguín L, correa D, Marcela A, Cáceres D, Varela M. Adherencia al tratamiento de hipertensión arterial: efectividad de un programa de intervención biopsicosocial. Univ. Psychol 2006; 5 (3): 535-547.

(20). Manzur F; Arrieta C. Estudio sociológico y del conocimiento de los factores de riesgo de las enfermedades cardiovasculares en la Costa Caribe Colombiana (Estudio Caribe). Rev. Col. Cardiol 2005; 12(3): 122-128.

(21). Libertad A, Yadmila LR, Orbay M, Anaya J, Vento F y Acosta M. Cumplimiento e incumplimiento del tratamiento antihiperten-sivo desde la perspectiva del paciente. Rev Cubana Salud Pública 2007; 33(3): 1-10. DOI: https://doi.org/10.1590/S0864-34662007000300013

(22). Potvin L, Richard L, Edwards A. Knowledge of cardiovascular disease risk factors among the Canadian population: relation-ships with indicators of socioeconomic status. Can Med Assoc J 2000; 162(9 Suppl): S5-11.

Published

2011-10-10

How to Cite

1.
Martinez JW, Villa P. JA, Quintero B. AM, Jaramillo A. J, Calderón F. V, Copete M. Ángela V. Frequency of cardiovascular risk factors in patients with hypertension in a second level hospital. Rev. Fac. Nac. Salud Pública [Internet]. 2011 Oct. 10 [cited 2025 Jan. 31];29(2):139-44. Available from: https://revistas.udea.edu.co/index.php/fnsp/article/view/5246

Issue

Section

Research